Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma
Deepak Rohila(University of California San Diego), Shweta Joshi(University of California San Diego)
Cited by 42
Related Papers
Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma
|Frontiers in Immunology|2023|17